NL-OMON55613招募中2 期
PDL-1 targeting in resectable oesophageal cancer: a phase II feasibility study of Atezolizumab and chemoradiation (PERFECT) - PERFECT
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Histologically proven adenocarcinoma of the esophagus or gastro esophageal
- •2. The tumor is surgically resectable
- •3. Patient is fit for surgery
排除标准
- •Past or current history of malignancy other than entry diagnosis interfering
- •with prognosis of esophageal cancer
研究者
相似试验
进行中（未招募）
1 期
PDL-1 targeting in resectable oesophageal cancer: a phase IB feasibility study of Atezolizumab and chemoradiation (PERFECT)oesophageal cancerEUCTR2016-004744-11-NLAcademic Medical Center
已完成
2 期
PDL-1 Targeting in Resectable Oesophageal CancerEsophageal Cancer, Stage IIEsophageal Cancer Stage IIINCT03087864Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)40
进行中（未招募）
不适用
Oesophageal squamous cell cancer: chemoradiotherapy versus chemotherapy and surgery - a feasibility study - Feasibility trial of chemoradiation or surgery for oesophageal canceroesophageal cancerMedDRA version: 12Level: LLTClassification code 10030151Term: Oesophageal cancerEUCTR2009-013877-16-GBniversity Hospitals Bristol NHS Foundation Trust
已完成
2 期
Targeting esophageal cancer with HDL nanoparticles: an imaging study<br>gullet cancer10017991esophageal cancerNL-OMON45362Academisch Medisch Centrum9
进行中（未招募）
1 期
Targeting esophageal cancer with HDL nanoparticles: an imaging studyPrimary esophageal cancerEUCTR2017-000724-10-NLAcademic Medical Center13